https://www.selleckchem.com/products/ABT-888.html
p.F972L was detected in patients with complete response to treatments. Moreover, a significant difference in ORR was observed in patients with NPM1_NR4A3 and SEPT6_TRIM33 fusions. _ gene fusion and mutated TP53 and Hippo pathways may serve as prognostic makers for B-cell lymphoma patients. SEPT6_TRIM33 gene fusion and mutated TP53 and Hippo pathways may serve as prognostic makers for B-cell lymphoma patients. The purpose of this study was set to investigate the prognostic role of plasmatic levels of heat shock protein 90 alpha (HSP90α)
Like
Comment
Share
